Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...

Explainable AI was harnessed to identify the contribution of follicle sizes to relevant downstream clinical outcomes. The researchers found that intermediately sized follicles were most important to ...

CLEVELAND, Ohio – Ask Chuck Prophet what brought him to Cumbia (Latin folk-rock with flair) music and you “figure out right quick” why he picked the profession he’s in. The singer ...

is celebrating his recovery thanks to a groundbreaking therapy available at the Roswell Park Comprehensive Cancer Center in Buffalo. Diagnosed with lymphoma in 2009, Vogelsang underwent a stem ...